* In a sample of 830 women, two-thirds achieved target blood pressure levels within one hour, and 77.4% had successful treatment within two hours without significant adverse effects.
* The findings suggest that nicardipine is a promising option for managing severe antepartum hypertension, with a high success rate and an acceptable safety profile, indicating its potential for clinical use.